Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

The clinical utility of C-peptide measurement in the care of patients with diabetes.

Jones AG, Hattersley AT.

Diabet Med. 2013 Jul;30(7):803-17. doi: 10.1111/dme.12159. Review.

2.
3.

C-peptide measurement: methods and clinical utility.

Bonser AM, Garcia-Webb P.

Crit Rev Clin Lab Sci. 1984;19(4):297-352. Review.

PMID:
6373142
4.
5.

Postprandial C-Peptide to Glucose Ratio as a Marker of β Cell Function: Implication for the Management of Type 2 Diabetes.

Saisho Y.

Int J Mol Sci. 2016 May 17;17(5). pii: E744. doi: 10.3390/ijms17050744. Review.

6.

Determination of C-peptide in children: when is it useful?

Besser RE.

Pediatr Endocrinol Rev. 2013 Jul;10(4):494-502. Review.

PMID:
23957200
7.

Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective.

Zaccardi F, Webb DR, Yates T, Davies MJ.

Postgrad Med J. 2016 Feb;92(1084):63-9. doi: 10.1136/postgradmedj-2015-133281. Epub 2015 Nov 30. Review.

PMID:
26621825
8.

Residual C-peptide in type 1 diabetes: what do we really know?

VanBuecken DE, Greenbaum CJ.

Pediatr Diabetes. 2014 Mar;15(2):84-90. doi: 10.1111/pedi.12135. Review.

PMID:
24645775
9.

Insulin-dependent diabetes mellitus: pathophysiology.

Gerich JE.

Mayo Clin Proc. 1986 Oct;61(10):787-91. Review.

PMID:
3528691
10.
11.

[The clinical utility of C-peptide measurement in diabetology].

Otto-Buczkowska E.

Pediatr Endocrinol Diabetes Metab. 2015;20(2):63-8. doi: 10.18544/PEDM-20.02.0004. Review. Polish.

PMID:
26615015
12.

[Clinical value of C-peptide determination].

Meier C, Ladewig A, Keller U, Berger W.

Praxis (Bern 1994). 1997 Aug 20;86(34):1289-95. Review. German.

PMID:
9381016
13.

[Progress in insulin therapy. V. Insulin therapy in noninsulin dependent diabetes mellitus].

Szurkowska M, Nazim A, Sieradzki J.

Przegl Lek. 1992;49(8):279-81. Review. Polish. No abstract available.

PMID:
1302350
14.

C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations.

Polonsky KS, Rubenstein AH.

Diabetes. 1984 May;33(5):486-94. Review.

PMID:
6373457
15.

[The clinical value of C-peptide assay (author's transl)].

Vialettes B, Vague P.

Diabete Metab. 1980 Sep;6(3):225-9. Review. French.

PMID:
7002655
16.

The expanding clinical use of C-peptide radioimmunoassay.

Rendell M.

Acta Diabetol Lat. 1983 Apr-Jun;20(2):105-13. Review.

PMID:
6410638
17.

[Treatment of diabetes mellitus: general goals, and clinical practice management].

Simó R, Hernández C.

Rev Esp Cardiol. 2002 Aug;55(8):845-60. Review. Spanish.

18.

[The natural history of diabetes with respect to disorders of insulin function].

Dorner M, Pinget M, Brogard JM, Sapin R, Paris-Bockel D, Levy P, Jung C.

Journ Annu Diabetol Hotel Dieu. 1984:51-71. Review. French. No abstract available.

PMID:
6399540
19.

[Amylin/IAPP (islet amyloid polypeptide)--physiology and clinical significance].

Ludvik B.

Wien Klin Wochenschr. 1997 Jun 6;109(11):379-83. Review. German.

PMID:
9281227

Supplemental Content

Support Center